Supply-side · Hospital & data groups
Hospital & data-org partnerships: clear control, reviewable, terminable
For hospital IT, medical affairs, ethics, legal, and data-group operations. The public page covers process and responsibility boundaries only; authorization packs, revenue share, and commercial terms exchange under NDA. Contracting entity: Beijing Langhui Technology Co., Ltd. (brand LumeSage).
Partnership flow (summary)
- Initial org call: intended modality / disease / residency preference
- Inventory: stock structure and eligible subset (summary-level)
- Authorization / ethics / security path confirmation
- On-prem or isolation plan (only when both sides confirm feasibility — never assumed)
- Small-batch acceptance: format, de-ID checks, sampling rules
- Use & access approval: who may view, train, or sublicense
- Phased delivery or controlled use
- Audit, incident notice, and termination
What hospitals care about most
- Control: who approves access; who holds mapping keys
- Residency: allowed or not; summary / features / de-ID objects
- De-ID duty: on-site vs joint; how verification is recorded
- Subcontracting: allowed or not; roster & confidentiality if yes
- Audit & notice: hospital sampling; breach notice timelines
What data groups focus on
- Authorization boundaries and downstream use limits
- Multi-party revenue and metering (batch / license scope)
- Audit pack list (summaries public; originals controlled)
- No implication that “holding hospital data” equals full train/sublicense rights
- No promised revenue or purchase volume
First call only needs this (no raw records)
- Organization name and contact role
- Data types that may be in scope (imaging / pathology / text — high level)
- One usable contact channel
- Preference for on-prem processing vs discussable off-site
Authorization status, ethics approvals, contracts, and identity proofs are follow-up materials — not first-submit requirements.
Compliance discipline
Not a medical-device promotion; no clinical efficacy claims. “Data stays on-prem” and isolation paths enter the contract only when both sides confirm feasibility. Cross-border transfer requires a separate written agreement.
Operating & contracting entity: Beijing Langhui Technology Co., Ltd. (brand LumeSage). Business: date@lumesage.com · +86 15010400907